Novartis Hits Mylan With Patent Suit Over Dementia Patch
Novartis Pharmaceuticals Corp., fresh off a win in a patent dispute with a generic-drug maker over its patch that treats Alzheimer's disease, in a Delaware federal court on Thursday filed a...To view the full article, register now.
Already a subscriber? Click here to view full article